Status:

COMPLETED

Digoxin Withdrawal in Stable Heart Failure

Lead Sponsor:

The Alfred

Conditions:

Heart Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Heart failure is a chronic condition in which the heart fails to function as a pump to move blood around the body. This sets up a complex physiologic response to compensate, which include activation o...

Eligibility Criteria

Inclusion

  • Over the age of 18 years
  • In sinus rhythm at the time of randomisation
  • Have a LVEF \<0.45 and a left ventricular end-diastolic dimension \>60 mm or \>34 mm/m2
  • Are receiving ACE inhibitor, β-blocker and diuretic therapy at the optimal doses.
  • Has been receiving digoxin therapy for at least 3 months at a dose that results in digoxin plasma levels of 0.4-0.8 on 2 consecutive blood tests (at least 1 weeks apart) prior to randomisation. The dose of digoxin must remain stable for at least 2 weeks prior to randomisation.
  • Documented, stable heart failure. Must have at least 1 of the following:
  • Hospitalised with a discharge diagnosed of heart failure in the last 6 months
  • Evidence of pulmonary congestion on chest X-ray
  • Evidence of heart failure on echocardiogram
  • Evidence of heart failure on ECG
  • Willing and able to provide informed consent

Exclusion

  • Systolic BP \>160mmHg or \<90mmHg
  • Diastolic BP \>95mmHg
  • Uncorrected primary valvular disease
  • Active myocarditis
  • Obstructive or restrictive Cardiomyopathy
  • Exercise capacity limited by other factors not including dyspnoea
  • Myocardial infarction within the previous 6 months
  • Stroke within the previous 12 months
  • Hospitalisation within one month of randomisation
  • A history of supraventricular arrhythmia or sustained ventricular arrhythmia
  • Claudication
  • Severe primary pulmonary (VC \<1.5L), renal or hepatic disease

Key Trial Info

Start Date :

August 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2015

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT01398371

Start Date

August 1 2011

End Date

June 1 2015

Last Update

June 1 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical Pharmacology, Alfred Hospital

Melbourne, Victoria, Australia, 3004